Chronic therapies are growing faster than the broader pharma market. Discover how four companies are using acquisitions, innovation, and portfolio…
The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed 5.5% to growth,…
Novo Nordisk cuts prices of Wegovy and Ozempic in India by up to 48% amid rising competition from cheaper semaglutide…
India ramps up enforcement against unauthorised sale and promotion of GLP-1 weight-loss drugs after generics hit the market, with inspections…
Nomura has a ‘Buy’ rating on Zydus Lifesciences, with the stock at Rs 891 and a target price of Rs…
Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7…
Semaglutide prices in India are set to drop sharply as generics enter the market after patent expiry, improving affordability for…
Several Indian companies including Coal India, Hindustan Aeronautics, ONGC, IRCTC and Torrent Pharma have announced interim dividends this week. Check…
Stocks to watch, February 17: Track key stock updates as indices signal a lower open and stay informed on Coal…
From generics to branded drugs, Jefferies’ latest pharma calls spotlight Alkem, Lupin, Sun Pharma, Torrent, and Zydus as India’s key…
Nomura keeps its Nifty target at 26,140, signaling limited upside. The firm pivots toward domestic consumption and pharma, adding Swiggy,…
Track top stocks like KEC International, RVNL, Brigade Enterprises, and more as corporate moves could impact markets today—discover the latest…
While pharmaceutical sector faces pressure because of US tariff uncertainty, Laboratory stocks are gradually recovering and gaining strength. These stocks…
Watch telecom, energy, pharma stocks today; key Q4 results and market cues to guide investors. Explore the highlighted stocks now!
Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus.
Nuvama cuts Alkem Lab’s target price by 3.5% amid slow acute business; read more for insights on future projections.
The MSCI rebalancing takes effect today, with Indian equities set to attract $1.7 billion inflows. HDFC Bank and five other…
As per IQVIA (SSA) data, for Q2FY25, the company registered a growth of 6.3 percent YoY vs. the Indian Pharmaceutical…